Vertaling van "about this new activity within " (Nederlands → Frans) :

Various roadshows were organised in order to inform the FAMHP stakeholders about this new activity within the FAMHP and to provide a coherent explanation of recent regulations regarding medicines for veterinary use and the distribution of these products in particular; the roadshows were organised for and in collaboration with the veterinarian professional organisations.
Various roadshows were organised in order to inform the FAMHP stakeholders about this new activity within the FAMHP and to provide a coherent explanation of recent regulations regarding medicines for veterinary use and the distribution of these products in particular; the roadshows were organised for and in collaboration with the veterinarian professional organisations.

At the start of March 2008 an International relations (IR) Unit was created at the FAMHP through the appointment of an IR coordinator. The aim in establishing this unit is to organise the FAMHP’s activities within the context of international relations by coordinating internal and external exchange of information and defending the Belgian position to national and international authorities.
At the start of March 2008 an International relations (IR) Unit was created at the FAMHP through the appointment of an IR coordinator. The aim in establishing this unit is to organise the FAMHP’s activities within the context of international relations by coordinating internal and external exchange of information and defending the Belgian position to national and international authorities.

It groups together the associations and organisations working in the field of mourning, as well as family planning services that have accepted to integrate this activity within the services they offer.
Cette structure rassemble les associations et organisations actives dans le domaine du deuil ainsi que des plannings familiaux ayant accepté d’intégrer cette activité au sein des services qu’ils proposent.

In fact, it may be the most sensitive information there is and as new discoveries are made, and more is learned about what your genes say about you, this information is likely to become ever more sensitive over time" , centraal of perifeer: " Individuals want to have a more active role in the creation, storage and protection of their personal genetic information" , of aan de logische gevolgen van: " Not supplying genetic testing services direct-to-the-public to those under the age of 16 or to those not able to make a competent decision regarding testing" , op het huidige waarschijnlijk al meest gevraagde toepassingsgebied in de embryonale en foetale geneeskunde: " That the DTC offer of preconceptional carrier testing questions the offer of preconception care and the systematic offer of carrier tests towards a population of couples that are planning a pregnancy.
En fait, c'est peut-être même l'information la plus sensible qui soit, et si de nouvelles découvertes sont faites et que les connaissances avancent sur ce que vos gènes disent de vous, cette information deviendra probablement toujours davantage sensible au fil du temps.], centrale ou périphérique « Individuals want to have a more active role in the creation, storage and protection of their personal genetic information [traduction libre: Les gens veulent prendre une part plus active dans la genèse, la conservation et la protection de leurs données génétiques personnelles] ; les conséquences logiques de « Not supplying genetic testing services direct-to-the-public to those under the age of 16 or to those not able to make a competent decision regarding testing » [traduction libre: Ne pas fournir des tests génétiques en vente directe aux personnes âgées de moins de 16 ans ou aux personnes qui n'ont pas la capacité de prendre une décision en matière de dépistage] sur le champ d'application vraisemblablement le plus sollicité actuellement en médecine embryonnaire et fœtale : « That the DTC offer of preconceptional carrier testing questions the offer of preconception care and the systematic offer of carrier tests towards a population of couples that are planning a pregnancy.

Furthermore an expert committee, the Committee for Advanced Therapies (CAT), was A transversal working group has been established within the FAMHP which is responsible for the coordination of this matter and the introduction of the new regulations in practice. This consultation process arrived at the following decisions:
Furthermore an expert committee, the Committee for Advanced Therapies (CAT), was A transversal working group has been established within the FAMHP which is responsible for the coordination of this matter and the introduction of the new regulations in practice. This consultation process arrived at the following decisions:

This release contains forward-looking information about an agreement by Pfizer to acquire FoldRx, and about FoldRx’s product candidate tafamidis, its other clinical and preclinical development programs and its technology platform, including their potential benefits, that involves substantial risks and uncertainties. Such risks and uncertainties include, among other things, the satisfaction of conditions to closing the agreement; the uncertainties inherent in research and development; whether and when a new drug application for tafamidis will be filed with the FDA; decisions by regulatory authorities regarding whether and when to approve any drug applications that have been or may be filed for tafamidis and that may be filed for any other product candidates that may be generated by FoldRx’s technology platform as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of tafamidis and such other product candidates; and competitive developments. A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and in its reports on Form 10-Q and Form 8-K.
Such risks and uncertainties include, among other things, the satisfaction of conditions to closing the agreement; the uncertainties inherent in research and development; whether and when a new drug application for tafamidis will be filed with the FDA; decisions by regulatory authorities regarding whether and when to approve any drug applications that have been or may be filed for tafamidis and that may be filed for any other product candidates that may be generated by FoldRx’s technology platform as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of tafamidis and such other product candidates; and competitive developments.

Please submit your email address to us if you wish to receive an e-mail notification about new content on this website.
Veuillez-nous transmettre votre adresse électronique pour être avisé par courriel de tout nouveau contenu de ce site Web.

In a report of 15 January 2009, the European Food Safety Authority (EFSA) gives its opinion about the innocuousness of taurine and D-glucuronolactone as individual ingredients of energy drinks. This is based on new data from the literature and recent studies by the same applicant (EFSA, 2009).
Enfin, dans un rapport du 15 janvier 2009, l’European Food Safety Authority (EFSA) se prononce sur l’innocuité de la taurine et de la D-glucuronolactone en tant qu’ingrédients individuels de boissons énergisantes en se fondant sur les données récentes de la littérature et de nouvelles études fournies par le même pétitionnaire mais ne procède pas à une évaluation de l’innocuité de ces boissons en tant que telles (EFSA, 2009).

This explains the setting up of a new structure using messages of very general interest (15 questions - 15 answers) aimed at all listeners belonging to all age groups, and especially isolated people, who do not read papers or magazines and do not listen to broadcasts about depression, which require a personal choice and selection to begin with.
Ceci explique une structure nouvelle utilisant des messages d’intérêt très général (15 questions – 15 réponses) à destination de tous les auditeurs de tous âges dont notamment les personnes isolées, celles qui ne lisent pas les journaux et magazines, qui ne suivent pas non plus les émissions consacrées à la dépression qui appellent à un choix et une sélection personnelle au départ.

In this first “annual report”, we have chosen to describe the transition from the DG Medicinal Products of the FPS Public Health to an autonomous medicines agency and provide more details about a number of activities in 2007.
In this first “annual report”, we have chosen to describe the transition from the DG Medicinal Products of the FPS Public Health to an autonomous medicines agency and provide more details about a number of activities in 2007.